Pfizer’s Covid vaccine is 95% effective and has now passed safety checks

The Daily Star’s FREE newsletter is spectacular! Sign up today for the best stories straight to your inbox

The coronavirus vaccine from Pfizer – which is due to be rolled out across the UK before the end of this year – is 95% effective and has passed its safety checks, according to further data from the firm.

Pfizer Inc said on Wednesday that final results from the late-stage trial of its COVID-19 vaccine show it was 95% effective, and that it now has the required two-months of safety data to be able to apply for emergency authorisation in America.

The drugmaker said efficacy of the vaccine developed with German partner BioNTech SE was consistent across age and ethnicity demographics, and that there were no major side effects – sparking hopes immunisation could be rolled out across the world.

And perhaps most promisingly, the jab appears to be more than 94% effective in protecting adults over the age of 65 – the group most at risk from coronavirus.

The UK has secured 40 million doses in total of the vaccine, with 10 million due in the country by the end of the year if the jab is approved.

People will need two doses, meaning not enough vaccine has been secured for the entire UK population.

Another jab, from US firm Moderna, was shown this week in early data to be almost 95% effective.

The UK has ordered five million doses of that jab, and also awaits the results of the Oxford University and AstraZeneca vaccine study – which is due to report soon.

Changes to the Human Medicine Regulations announced in October will allow the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise temporary supply of vaccines, if one becomes available before 2021.

  • Coronavirus

Source: Read Full Article